TuHURA BIOSCIENCES, INC./NV Class of Warrant or Right, Outstanding
TuHURA BIOSCIENCES, INC./NV (HURA) had Class of Warrant or Right, Outstanding of 32.29 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 32.29M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 32.37M shares.
- 2020-03-31: Class of Warrant or Right, Outstanding 250.00K shares.
- 2019-12-31: Class of Warrant or Right, Outstanding 250.00K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 32.29M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 32.37M shares 10-Q · filed 2026-05-15 | |
| 2020-03-31 | 250.00K shares 10-Q · filed 2020-05-13 | |
| 2019-12-31 | 250.00K shares 10-Q · filed 2020-02-13 | |
| 2018-03-31 | 14.28M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 15.03M shares 10-Q · filed 2018-02-14 | |
| 2016-03-31 | 18.39M shares 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 17.89M shares 10-Q · filed 2016-02-12 | |
| 2015-09-30 | 17.90M shares 10-Q · filed 2015-11-16 | |
| 2015-06-30 | 89.43K shares 10-K · filed 2017-09-27 | 5.55M shares 10-K · filed 2015-09-03 |
| 2015-03-31 | 13.47M shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 15.41M shares 10-Q · filed 2015-02-12 | |
| 2014-09-30 | 17.79M shares 10-Q · filed 2014-11-07 | |
| 2014-06-30 | 5.99M shares 10-K · filed 2015-11-16 | |
| 2014-03-31 | 2.17M shares 10-Q · filed 2014-05-15 | |
| 2013-12-31 | 6.00M shares 10-K · filed 2014-08-28 | |
| 2013-09-30 | 6.00M shares 10-Q · filed 2013-11-08 | |
| 2013-06-30 | 6.20M shares 10-K · filed 2015-11-16 | |
| 2013-03-31 | 6.20M shares 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 950.00K shares 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |